Monday June 26th 2017

Archive for April, 2016

Safety tips to prevent slips and falls among seniors

Safety tips to prevent slips and falls among seniors

May is National Trauma Awareness Month, and this year the American Trauma Society is raising awareness about senior safety and falls with "Safe Steps for Seniors." The Stony Brook Trauma Center is taking steps to shed light on the matter to help prevent serious injuries [Read More]

Veto on Home Modifications Bill in Maine Unanimously Overridden

Veto on Home Modifications Bill in Maine Unanimously Overridden

/About-the-Society/News/Veto-on-Home-Modifications-Bill-in-Maine-Unanimous [Read More]

EMA Panel Backs Daclizumab (Zinbryta) for Multiple SclerosisEMA Panel Backs Daclizumab (Zinbryta) for Multiple Sclerosis

EMA Panel Backs Daclizumab (Zinbryta) for Multiple SclerosisEMA Panel Backs Daclizumab (Zinbryta) for Multiple Sclerosis

Daclizumab, a once-monthly injection, offers a targeted mechanism of action that is not expected to cause broad and prolonged immune cell depletion. International Approvals (Source: Medscape Neurology and Neurosurgery Headlines)MedWorm Message: Have you tried our new [Read More]

 Page 1 of 33  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]